Neeraj Kapur

998 total citations
36 papers, 750 citations indexed

About

Neeraj Kapur is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Neeraj Kapur has authored 36 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Neeraj Kapur's work include Inflammatory Bowel Disease (8 papers), Chemokine receptors and signaling (7 papers) and Immunotherapy and Immune Responses (6 papers). Neeraj Kapur is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Chemokine receptors and signaling (7 papers) and Immunotherapy and Immune Responses (6 papers). Neeraj Kapur collaborates with scholars based in United States, India and France. Neeraj Kapur's co-authors include Hina Mir, Shailesh Singh, Patrick P. Carriere, Dominique N. Gales, James W. Lillard, Subrat Kumar Panda, Hemlata Durgapal, Robert J. Friedman, Sejong Bae and Rajesh Singh and has published in prestigious journals such as Gastroenterology, Cancer Research and Scientific Reports.

In The Last Decade

Neeraj Kapur

35 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neeraj Kapur United States 15 227 212 140 97 85 36 750
Raluca Costache Romania 11 304 1.3× 186 0.9× 90 0.6× 72 0.7× 171 2.0× 65 900
Jui‐Chieh Chen Taiwan 16 298 1.3× 74 0.3× 73 0.5× 69 0.7× 96 1.1× 35 731
Ji-Hua Dong China 20 403 1.8× 127 0.6× 155 1.1× 53 0.5× 94 1.1× 39 1.1k
Bo Jin China 15 255 1.1× 78 0.4× 162 1.2× 75 0.8× 62 0.7× 42 739
Xin‐Ying Tang China 16 316 1.4× 182 0.9× 124 0.9× 16 0.2× 109 1.3× 40 933
Khaled Alhosaini Saudi Arabia 16 278 1.2× 85 0.4× 130 0.9× 23 0.2× 48 0.6× 44 794
Weifeng Huang China 17 351 1.5× 89 0.4× 31 0.2× 40 0.4× 102 1.2× 38 787
Nils H. Thoennissen Germany 21 587 2.6× 193 0.9× 141 1.0× 16 0.2× 99 1.2× 37 1.3k
Uzma Saqib India 15 456 2.0× 97 0.5× 369 2.6× 28 0.3× 200 2.4× 27 1.0k

Countries citing papers authored by Neeraj Kapur

Since Specialization
Citations

This map shows the geographic impact of Neeraj Kapur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeraj Kapur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeraj Kapur more than expected).

Fields of papers citing papers by Neeraj Kapur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neeraj Kapur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeraj Kapur. The network helps show where Neeraj Kapur may publish in the future.

Co-authorship network of co-authors of Neeraj Kapur

This figure shows the co-authorship network connecting the top 25 collaborators of Neeraj Kapur. A scholar is included among the top collaborators of Neeraj Kapur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neeraj Kapur. Neeraj Kapur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, Evan B., Neeraj Kapur, Tatiana Goretsky, et al.. (2025). Phosphatidylinositol 3-Kinase Signaling Enhances Intestinal Crypt Epithelial Cell Recovery after Radiation. American Journal Of Pathology. 195(8). 1411–1427.
2.
Hassan, Syed Adeel, et al.. (2024). Disease clearance in ulcerative colitis: A new therapeutic target for the future. World Journal of Gastroenterology. 30(13). 1801–1809. 4 indexed citations
3.
Hassan, Syed Adeel, et al.. (2024). REPRESSED MITOCHONDRIAL FUNCTION LIMITS CRYPT FISSIONING IN INFLAMMATORY BOWEL DISEASE. Gastroenterology. 166(3). S84–S84. 1 indexed citations
4.
Kapur, Neeraj, et al.. (2024). Su1012 COLORECTAL CANCER RELATED MORTALITY TRENDS IN APPALACHIAN KENTUCKY FROM 1999-2020: A PERSISTENT HEALTHCARE DISPARITY. Gastroenterology. 166(5). S–636. 1 indexed citations
5.
Kim, Jong Hyun, Syed Adeel Hassan, Tatiana Goretsky, et al.. (2023). AUPHOS, A NOVEL DRUG THAT IMPROVES COLITIS BY MICROBIOME INDUCED METABOLIC CHANGES. Inflammatory Bowel Diseases. 29(Supplement_1). S49–S49. 1 indexed citations
6.
Kapur, Neeraj, Luksana Chaiswing, Jong Hyun Kim, et al.. (2023). A NOVEL DRUG THERAPY INDUCES MITOCHONDRIAL BIOGENESIS AND ATTENUATES COLITIS. Inflammatory Bowel Diseases. 29(Supplement_1). S55–S55. 1 indexed citations
7.
Vekaria, Hemendra J., et al.. (2023). BUTYRATE-INDUCED MITOCHONDRIAL FUNCTION IMPROVES BARRIER FUNCTION IN INFLAMMATORY BOWEL DISEASE (IBD). Inflammatory Bowel Diseases. 29(Supplement_1). S71–S72. 2 indexed citations
8.
Vekaria, Hemendra J., et al.. (2023). BUTYRATE-INDUCED MITOCHONDRIAL FUNCTION IMPROVES BARRIER FUNCTION IN INFLAMMATORY BOWEL DISEASE (IBD). Gastroenterology. 164(4). S91–S91. 3 indexed citations
9.
Mir, Hina, Neeraj Kapur, Dominique N. Gales, et al.. (2021). CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling. Cancers. 13(14). 3568–3568. 12 indexed citations
10.
Mir, Hina, et al.. (2019). Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer. Cancers. 11(12). 1857–1857. 28 indexed citations
11.
Mir, Hina, et al.. (2019). CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival. Scientific Reports. 9(1). 4014–4014. 52 indexed citations
12.
Mir, Hina, Gurpreet Kaur, Neeraj Kapur, et al.. (2019). Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation. Scientific Reports. 9(1). 2527–2527. 25 indexed citations
13.
Mir, Hina, et al.. (2019). Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell International. 19(1). 98–98. 50 indexed citations
14.
Kapur, Neeraj, et al.. (2018). Abstract 312: Emodin inhibits colon cancer by modulating apoptotic and cell survival signals. Cancer Research. 78(13_Supplement). 312–312. 2 indexed citations
15.
Mir, Hina, et al.. (2018). Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World Journal of Surgical Oncology. 16(1). 108–108. 186 indexed citations
16.
Mir, Hina, Neeraj Kapur, Rajesh Singh, et al.. (2016). Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors. Cell Cycle. 15(6). 819–826. 37 indexed citations
17.
Kapur, Neeraj, Hina Mir, Uma Krishnamurti, et al.. (2016). CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition. British Journal of Cancer. 114(12). 1343–1351. 45 indexed citations
18.
Panda, Subrat Kumar, et al.. (2014). Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein. Journal of General Virology. 95(8). 1689–1700. 48 indexed citations
19.
Rehman, Shagufta, Neeraj Kapur, Hemlata Durgapal, & Subrat Kumar Panda. (2007). Subcellular localization of hepatitis E virus (HEV) replicase. Virology. 370(1). 77–92. 50 indexed citations
20.
Kapur, Neeraj & Robert J. Friedman. (2002). Oral Ketamine: A Promising Treatment for Restless Legs Syndrome. Anesthesia & Analgesia. 94(6). 1558–1559. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026